Monopoli A - Search Results

1

Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine.

Monopoli A, Conti A, Zocchi C, Casati C, Volpini R, Cristalli G, Ongini E. Monopoli A, et al. Arzneimittelforschung. 1994 Dec;44(12):1296-304. Arzneimittelforschung. 1994. PMID: 7848347

2

Telemetry monitoring of hemodynamic effects induced over time by adenosine agonists in spontaneously hypertensive rats.

Casati C, Monopoli A, Forlani A, Bonizzoni E, Ongini E. Casati C, et al. Among authors: monopoli a. J Pharmacol Exp Ther. 1995 Nov;275(2):914-9. J Pharmacol Exp Ther. 1995. PMID: 7473182

3

Modeling hemodynamic profiles by telemetry in the rat. A study with A1 and A2a adenosine agonists.

Bonizzoni E, Milani S, Ongini E, Casati C, Monopoli A. Bonizzoni E, et al. Among authors: monopoli a. Hypertension. 1995 Apr;25(4 Pt 1):564-9. doi: 10.1161/01.hyp.25.4.564. Hypertension. 1995. PMID: 7721399

4

2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists.

Cristalli G, Camaioni E, Vittori S, Volpini R, Borea PA, Conti A, Dionisotti S, Ongini E, Monopoli A. Cristalli G, et al. Among authors: monopoli a. J Med Chem. 1995 Apr 28;38(9):1462-72. doi: 10.1021/jm00009a007. J Med Chem. 1995. PMID: 7739005

5

Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine.

Monopoli A, Conti A, Dionisotti S, Casati C, Camaioni E, Cristalli G, Ongini E. Monopoli A, et al. Arzneimittelforschung. 1994 Dec;44(12):1305-12. Arzneimittelforschung. 1994. PMID: 7848348

6

Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.

Casati C, Monopoli A, Dionisotti S, Zocchi C, Bonizzoni E, Ongini E. Casati C, et al. Among authors: monopoli a. J Pharmacol Exp Ther. 1994 Mar;268(3):1506-11. J Pharmacol Exp Ther. 1994. PMID: 8138961

7

2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.

Cristalli G, Volpini R, Vittori S, Camaioni E, Monopoli A, Conti A, Dionisotti S, Zocchi C, Ongini E. Cristalli G, et al. Among authors: monopoli a. J Med Chem. 1994 May 27;37(11):1720-6. doi: 10.1021/jm00037a024. J Med Chem. 1994. PMID: 8201607

8

Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues.

Conti A, Monopoli A, Gamba M, Borea PA, Ongini E. Conti A, et al. Among authors: monopoli a. Naunyn Schmiedebergs Arch Pharmacol. 1993 Jul;348(1):108-12. doi: 10.1007/BF00168545. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 8377834

9

The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.

Zocchi C, Ongini E, Conti A, Monopoli A, Negretti A, Baraldi PG, Dionisotti S. Zocchi C, et al. Among authors: monopoli a. J Pharmacol Exp Ther. 1996 Feb;276(2):398-404. J Pharmacol Exp Ther. 1996. PMID: 8632302

10

Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit.

Casati C, Forlani A, Lozza G, Monopoli A. Casati C, et al. Among authors: monopoli a. Pharmacol Res. 1997 Jan;35(1):51-5. doi: 10.1006/phrs.1996.0114. Pharmacol Res. 1997. PMID: 9149316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters